SmiLe Incubator

Yazen is a digital healthcare platform specializing in personalized weight loss programs. It connects users with medical professionals, including doctors, dietitians, and personal trainers, to create tailored weight management plans combining lifestyle coaching and medical treatments.

Call Knut is a company that develops communication software aimed at monitoring elderly individuals, particularly those with chronic diseases. The company's innovative platform leverages artificial intelligence to facilitate phone calls and initiate automated conversations with seniors. This technology allows caregivers and family members to assess the well-being of elderly users by analyzing their voice during calls, which helps in detecting potential health issues. By focusing on effective and unobtrusive monitoring, Call Knut aims to enhance the quality of remote care for the elderly population.

Saveggy develops an edible, bio-based coating for fruit and vegetables, replacing plastic packaging while maintaining protective properties. This reduces food waste along supply chains and ensures compliance with EU regulations.

Manje Health is a search and discovery platform for chronic disease treatment.

Xaga Surgical innovates safer medical needles to minimize infection risks. Its proprietary needle design reduces bacterial transfer upon insertion, enhancing patient safety during procedures like prostate cancer diagnosis.

TIGERQ specializes in gene editing solutions, combining proprietary sequencing algorithms with efficient sample processing services. The company focuses on commercializing services related to CRISPR-Cas9 technology for accurate analysis of complex genetic changes, aiming to accelerate drug research and development.

Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke.

In2cure is a biotechnology company focused on developing innovative peptide-based drugs aimed at preventing and treating inflammatory diseases and infections. The company harnesses new scientific discoveries related to natural host defenses to create therapies that feature anti-endotoxic properties. In2cure's drugs are designed using sequences that mimic protein fragments naturally found in the human body, which allows for the production of anti-inflammatory medications that are less toxic and more soluble. This approach not only enhances the efficacy of the treatments but also promotes the generation of healing peptides during instances of wounding and inflammation.

Thyrolytics is a company focused on developing an innovative diagnostic device that measures serum levels of free T4 and T3, key thyroid hormones. Utilizing advanced nanotechnology and protein engineering, Thyrolytics offers a platform that provides direct measurements of thyroid hormone levels, enhancing the accuracy and reliability of the results. This approach results in a cost-effective point-of-care diagnostic method, enabling individuals to effectively monitor their thyroid health. By addressing the need for precise and accessible thyroid diagnostics, Thyrolytics aims to improve health outcomes for those managing thyroid conditions.

ReceptorPharma is a drug discovery company focused on developing innovative treatments for Alzheimer's disease through a novel mechanism of action. The company aims to address the needs of patients with early Alzheimer's who retain their cognitive abilities, potentially reversing the disease's effects. In addition to Alzheimer's, ReceptorPharma is also engaged in researching and developing therapies for various other debilitating conditions, including specific types of cancer, by utilizing G-protein-coupled receptors as drug targets. Through its unique approach, ReceptorPharma seeks to advance therapeutic options for patients facing challenging health issues.

Bionamic specializes in providing innovative solutions for the analysis of life science data, specifically targeting challenges in biopharma research and development. The company has developed a comprehensive data management platform that acts as a single source for all antibody-related discovery and development data. This platform is designed to streamline the process of navigating and interpreting complex datasets, thereby reducing or eliminating manual steps between raw data and actionable results. By enhancing researchers' ability to understand their data, Bionamic aims to facilitate more informed decision-making in the life sciences sector.

SAGA Diagnostics AB is a Swedish company specializing in personalized cancer diagnostics and disease monitoring through molecular genetic analyses, focusing on circulating tumor DNA (ctDNA). Founded in 2016 as a spin-out from a research group at Lund University, SAGA aims to enhance precision cancer medicine and improve patient survival rates with its minimally-invasive liquid biopsy testing services. The company provides a range of services, including gene mutation analysis and treatment monitoring, utilizing advanced technologies such as massively parallel sequencing. SAGA's proprietary tests enable oncologists and biopharmaceutical companies to detect actionable mutations, stratify patient groups, and monitor treatment responses with high sensitivity, thereby contributing significantly to advancements in cancer research and clinical diagnostics.

Medow designs and develops innovative healthcare products aimed at enhancing efficiency, patient comfort, and joy. Their flagship product is a reusable slap-on bracelet designed to securely hold intravenous tubes in place during treatments, reducing the need for frequent adjustments by nurses.

Medotemic develops healthcare mobile systems for objective gait deviation analysis, typically resulting from injury or pain. The platform collects sensor data via smartphones during walking and running and analyzes it with proprietary algorithms to generate movement parameters. It provides training tools to measure progress, raise awareness, and motivate adherence to a training plan, and enables remote monitoring by delivering immediate, objective feedback to patients and professionals to support treatment and recovery.

POOW Applications has developed The Food Hero app that helps children with different types of eating disorders.

Gedea Biotech AB, founded in 2015 and based in Lund, Sweden, specializes in the development of antibiotic-free treatments for vaginal fungal infections. The company focuses on creating a natural product, GA101, designed to treat and prevent these infections, which affect a significant percentage of women throughout their lives. GA101 functions by lowering the vaginal pH, providing a physical barrier, and inhibiting the formation of biofilms. This innovative approach aims to offer women a safe and effective alternative to traditional antibiotic treatments, promoting better vaginal health without the associated risks of antibiotic use.

Truly Labs specializes in providing customized in vitro and in vivo services, focusing on drug delivery and biomarker analysis. The company offers high-quality solutions that integrate pharmacology programs, including the design and execution of tailored studies. By utilizing established kits for biomarker analysis, Truly Labs delivers essential data to large pharmaceutical and biotechnology companies, aiding them in preclinical development and clinical design processes. Through its expertise, Truly Labs plays a crucial role in advancing pharmaceutical research and development.

Founded in 2014, Cellevate specializes in developing advanced 3D cell culture systems using nanofiber technology. Its patented platform enables the creation of consistent and porous networks of nanofibers, serving as realistic in-vitro models for scientific research and development across various industries.

MedVasc is a medical device company focused on enhancing the treatment of varicose veins. The company has developed a patented medical instrument that aims to improve the anesthetic procedure associated with varicose vein treatments. By minimizing pain during these procedures, MedVasc's device provides a more comfortable experience for patients, contributing to advancements in healthcare technology.

Speximo AB is a research-based company located in Lund, Sweden, specializing in sustainable emulsion stabilization technology. Founded in 2012, the company develops a patented emulsifier derived from quinoa starch, which enables the creation of surfactant-free Pickering-type emulsions. These emulsions are applicable in the cosmetics, pharmaceutical, and food industries, allowing for the formulation of environmentally friendly products such as creams and ointments. Speximo's technology not only stabilizes emulsions but also facilitates the encapsulation of high-value ingredients, enhancing the texture and efficacy of end products. The company collaborates closely with researchers from Lund University and Malmö University to explore the fundamental properties and applications of its technology, contributing to the advancement of sustainable practices in product development.

SARomics Biostructures AB is a Swedish company specializing in structural biology and structure-based drug discovery services for biotech and pharmaceutical companies, as well as non-profit institutions globally. Founded in 2006 and located in Lund, the company provides a comprehensive suite of services that includes crystallography, NMR spectroscopy, and gene-to-structure solutions, which encompass protein cloning, expression, purification, and structure determination. Additionally, SARomics offers kinase structures and related programs, hit identification, optimization services, and computational chemistry. Their work aids clients in understanding the interactions between drug substances and target molecules, facilitating the efficient development of new drugs. The company’s expertise in protein characterization and structure-activity relationship optimization further enhances its capability to support drug discovery projects from initial concept through to lead generation.